Our latest podcast is up, ad-free for our subscribers.
In conversation with professor Shane O'Mara of Trinity College Dublin.
Novo Nordisk has become Europe's largest, most valuable, company on the back of some new weight-loss drugs.
Is the hype justified?
It's early days but the preliminary evidence is an emphatic yes!
There are familiar caveats: potential …
Listen to this episode with a 7-day free trial
Subscribe to The Other Hand to listen to this post and get 7 days of free access to the full post archives.
